Related Experiment Video
Updated: Mar 28, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
A Case of Tuberculous Pericardial Effusion with Concurrent SARS-CoV-2 Infection in an Undernourished Child
Renuka Jadhav1, Shruti Gaonkar, Vineeta Pande
1Department of Paediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.
Insights
Tuberculosis (TB) pericardial effusion is a severe condition in children, particularly when co-infected with SARS-CoV-2. Early diagnosis and treatment are crucial for favorable outcomes in malnourished children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- Tuberculosis (TB) remains a significant cause of childhood morbidity and mortality globally.
- Tuberculous pericardial effusion is a rare but severe extrapulmonary manifestation of TB.
- Concurrent viral infections, like SARS-CoV-2, can complicate TB cases.
Purpose of the Study:
- To report a rare case of tuberculous pericardial effusion with concurrent SARS-CoV-2 infection in a malnourished child.
- To discuss the diagnostic challenges and clinical management of this dual infection.
- To highlight the importance of clinical suspicion in endemic regions.
Main Methods:
- A single-center, descriptive case report of a 9-year-old malnourished, unvaccinated male child.
- Evaluation included clinical assessment, imaging, pericardial fluid analysis, Mantoux test, Cartridge-based Nucleic Acid Amplification Test (CBNAAT), and SARS-CoV-2 RT-PCR.
- Treatment involved therapeutic pericardiocentesis, anti-tubercular therapy, and corticosteroids.
Main Results:
- The child presented with acute respiratory distress and large pericardial effusion with early tamponade.
- Pericardial fluid analysis showed lymphocytic exudate and elevated adenosine deaminase; Mantoux test was positive.
- CBNAAT for TB was negative, but SARS-CoV-2 infection was confirmed via RT-PCR.
- The child showed significant improvement and excellent recovery after treatment.
Conclusions:
- Tuberculous pericardial effusion poses diagnostic challenges in pediatric patients, especially with co-infection like SARS-CoV-2.
- High clinical suspicion is vital in TB-endemic areas.
- Timely diagnosis and intervention are critical for positive outcomes in undernourished and unvaccinated children.
Abstract:
Tuberculosis (TB) continues to be a major cause of morbidity and mortality in children, especially in the endemic regions. Tuberculous pericardial effusion is a rare but severe extrapulmonary manifestation and may be further complicated by concurrent viral infections such as SARS-CoV-2. To describe a rare case of tuberculous pericardial effusion with concurrent SARS-CoV-2 infection in an undernourished child and to discuss the diagnostic challenges and clinical management. A single-center, descriptive case report from a tertiary care hospital. A 9-year-old underweight, malnourished, unvaccinated male child presenting with acute respiratory distress was evaluated clinically and with imaging. Pericardial fluid analysis, Mantoux test, Cartridge-based Nucleic Acid Amplification Test (CBNAAT), and SARS-CoV-2 RT-PCR were performed. Therapeutic pericardiocentesis and anti-tubercular treatment were administered. Investigations revealed a large pericardial effusion with early tamponade physiology. Pericardial fluid showed a lymphocytic exudate with elevated adenosine deaminase. Mantoux test was positive, supporting a diagnosis of tubercular pericarditis despite negative CBNAAT. Concurrent SARS-CoV-2 infection was confirmed on RT-PCR. The child improved significantly following pericardiocentesis, anti-tubercular therapy, corticosteroids, and supportive management, with excellent recovery at 1-month follow-up. Tuberculous pericardial effusion remains a diagnostic challenge in pediatric patients, especially when co-infected with SARS-CoV-2. A high clinical suspicion is essential in TB endemic regions. Early diagnosis and timely intervention can lead to favorable outcomes even in undernourished and unvaccinated children.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pericarditis II: Clinical Features and Diagnostic Tests
